What Researchers Did
The researchers compared two treatments for long-lasting diabetic foot ulcers, shockwave therapy and hyperbaric oxygen therapy, by taking tissue samples from the ulcer edge before and after treatment.
What They Found
This cohort study of diabetic foot ulcers found that tissue markers of blood vessel growth and regeneration rose significantly after shockwave therapy (ESWT) but not after hyperbaric oxygen therapy (HBOT). The ESWT group had 39 patients (44 ulcers) and received shockwave treatment twice per week for six treatments. The HBOT group had 38 patients (40 ulcers) and received daily hyperbaric oxygen for 20 treatments. After ESWT, vWF, VEGF, eNOS, PCNA and EGF increased and TUNEL decreased (p less than 0.05). After HBOT, the changes were not statistically significant (p greater than 0.05). The two groups were comparable before treatment, and after treatment the differences between groups were statistically significant, favouring ESWT.
What This Means for Canadian Patients
For people with chronic diabetic foot ulcers, this study measured tissue changes in ulcer biopsies and did not report whether ulcers healed. In this study, the tissue markers changed significantly after ESWT but not after HBOT. The abstract does not report healing rates or clinical outcomes, so it cannot show which treatment heals ulcers better.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
The abstract describes a cohort study rather than a randomized trial, so the groups may differ in ways not measured, and it reports tissue markers rather than ulcer healing or other patient outcomes.